Sabra Health Care REIT Q1 2026 Earnings Call Insights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 30 2026
0mins
Source: seekingalpha
- Strong Investment Liquidity: Sabra has closed or been awarded $400 million in investments year-to-date in Q1 2026, indicating robust deal flow and a strong competitive position in the market, with expectations to materially exceed total investments from 2025.
- Increased Private Pay Concentration: For the first time, private pay concentration has surpassed 50% of the portfolio, enhancing revenue stability and strengthening the company's market position in the healthcare sector.
- Solid Financial Performance: The normalized FFO per share for Q1 was $0.38, and normalized AFFO per share was $0.39, reflecting ongoing improvements in profitability, although management did not provide new per-share guidance figures.
- Strong Dividend Coverage: The Board declared a quarterly cash dividend of $0.30 per share, with a coverage ratio of 77%, indicating robust cash flow management that helps bolster investor confidence.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SBRA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SBRA
Wall Street analysts forecast SBRA stock price to rise
7 Analyst Rating
3 Buy
4 Hold
0 Sell
Moderate Buy
Current: 18.050
Low
20.00
Averages
20.83
High
22.00
Current: 18.050
Low
20.00
Averages
20.83
High
22.00
About SBRA
Sabra Health Care REIT Inc operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. The Company's primary business consists of acquiring, financing and owning real estate property to be leased to third-party tenants in the healthcare sector. The Company invests primarily in the United States nursing home industry, including skilled nursing and transitional care facilities, the United States and Canadian senior housing industry, which includes independent living, assisted living, memory care and continuing care retirement communities, select behavioral health and addiction treatment centers, and acute care and other hospitals. Its skilled nursing facilities provide services that include daily nursing, therapeutic rehabilitation, social services, activities, housekeeping, nutrition, medication management and administrative services for individuals.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Healthcare REIT Comparison: Community Healthcare Trust vs. Sabra Health Care
- Market Positioning of Community Healthcare Trust: Community Healthcare Trust focuses on smaller outpatient facilities in non-urban and suburban areas, with nearly 198 properties across 35 states, and major tenants like US HealthVest and Lifepoint Health contributing 7.3% and 6.4% of annual rent respectively, establishing a unique competitive edge in the healthcare real estate market.
- Financial Recovery: In FY 2025, Community Healthcare Trust reported approximately $121.2 million in revenue, reflecting a 4.7% growth year-over-year, with a net income of about $5.1 million and a net margin of 4.2%, indicating a stabilization in operational results after a prior year loss, thereby boosting investor confidence.
- Scale Advantage of Sabra Health Care REIT: Sabra Health Care REIT boasts a portfolio of nearly 361 properties and over 36,412 beds, achieving nearly $774.6 million in revenue for FY 2025, a 10.2% increase from the previous year, with a net income of approximately $155.6 million and a net margin of 20.1%, showcasing its profitability amid rising demand for long-term lease agreements.
- Risk and Valuation Comparison: Community Healthcare Trust faces risks from its concentration in the healthcare sector, particularly economic fluctuations in Texas and Florida, while Sabra is sensitive to rising interest rates that could increase debt costs; however, its future earnings estimates suggest a more attractive valuation, prompting investors to weigh market outlooks in their decisions.
See More
Analysis of Healthcare Real Estate Investment Prospects
- Community Healthcare Trust Overview: Community Healthcare Trust focuses on outpatient facilities in non-urban and suburban areas, owning nearly 198 properties across 35 states, with FY 2025 revenue of approximately $121.2 million, reflecting a 4.7% growth, indicating stability and growth potential in the healthcare real estate niche.
- Sabra Health Trust Advantages: Sabra Health Trust boasts a portfolio of nearly 361 properties and over 36,412 beds, with FY 2025 revenue nearing $774.6 million and a growth rate of about 10.2%, while its 20.1% net margin highlights profitability in the long-term lease and senior housing market.
- Financial Health Comparison: As of December 2025, Community Healthcare Trust has a debt-to-equity ratio of 1.2x and a current ratio of approximately 0.2x, whereas Sabra's ratios are 0.9x and 0.6x respectively, showcasing Sabra's relative advantage in financial leverage and liquidity.
- Market Risks and Opportunities: Community Healthcare Trust faces concentration risks in the healthcare sector, with about 26.7% of annual rent from Texas and Florida, while Sabra is sensitive to rising interest rates that could increase debt costs, requiring investors to weigh each company's market risks against future growth potential.
See More
Sabra Health Care REIT Q1 2026 Earnings Call Insights
- Strong Investment Liquidity: Sabra has closed or been awarded $400 million in investments year-to-date in Q1 2026, indicating robust deal flow and a strong competitive position in the market, with expectations to materially exceed total investments from 2025.
- Increased Private Pay Concentration: For the first time, private pay concentration has surpassed 50% of the portfolio, enhancing revenue stability and strengthening the company's market position in the healthcare sector.
- Solid Financial Performance: The normalized FFO per share for Q1 was $0.38, and normalized AFFO per share was $0.39, reflecting ongoing improvements in profitability, although management did not provide new per-share guidance figures.
- Strong Dividend Coverage: The Board declared a quarterly cash dividend of $0.30 per share, with a coverage ratio of 77%, indicating robust cash flow management that helps bolster investor confidence.
See More
Sabra (SBRA) Q1 2026 Earnings Transcript
See More
Sabra Health Care Declares Quarterly Dividend of $0.30
- Quarterly Dividend Announcement: Sabra Health Care declares a quarterly dividend of $0.30 per share, consistent with previous distributions, indicating the company's stable cash flow and commitment to shareholder returns.
- Yield Analysis: The forward yield of 5.9% reflects the company's attractiveness in the current market environment, potentially drawing more investor interest towards its stock.
- Financial Performance: Sabra Health Care reported FFO of $0.36, missing expectations by $0.01, while revenue of $211.9 million exceeded forecasts by $9.93 million, demonstrating the company's resilience in revenue growth.
- Future Outlook: Sabra anticipates FFO growth between 4.9% and 5.4% for 2026, while increasing investments in SHOP to capitalize on the upcoming silver tsunami market opportunities.
See More
Sabra Health Care Q1 Earnings Announcement Scheduled
- Earnings Release Date: Sabra Health Care (SBRA) is set to announce its Q1 2023 earnings on April 29th after market close, with consensus estimates predicting a Funds From Operations (FFO) of $0.37 and revenue of $216.44 million.
- FFO Growth Outlook: The company anticipates an FFO growth rate between 4.9% and 5.4% for 2026, indicating a strategic focus on accelerating investments in its Senior Housing Operating Platform (SHOP) to capitalize on demographic trends.
- 2025 Q4 Earnings Review: In its Q4 2025 earnings report, Sabra reported an FFO of $0.36, missing estimates by $0.01, while revenue of $211.9 million exceeded expectations by $9.93 million, demonstrating resilience in revenue growth despite slight FFO shortfall.
- Market Reaction: Although the FFO fell slightly short of expectations, the revenue beat may positively influence the stock price in the short term, reflecting market confidence in the company's future growth potential.
See More
Healthcare REIT Comparison: Community Healthcare Trust vs. Sabra Health Care
- Market Positioning of Community Healthcare Trust: Community Healthcare Trust focuses on smaller outpatient facilities in non-urban and suburban areas, with nearly 198 properties across 35 states, and major tenants like US HealthVest and Lifepoint Health contributing 7.3% and 6.4% of annual rent respectively, establishing a unique competitive edge in the healthcare real estate market.
- Financial Recovery: In FY 2025, Community Healthcare Trust reported approximately $121.2 million in revenue, reflecting a 4.7% growth year-over-year, with a net income of about $5.1 million and a net margin of 4.2%, indicating a stabilization in operational results after a prior year loss, thereby boosting investor confidence.
- Scale Advantage of Sabra Health Care REIT: Sabra Health Care REIT boasts a portfolio of nearly 361 properties and over 36,412 beds, achieving nearly $774.6 million in revenue for FY 2025, a 10.2% increase from the previous year, with a net income of approximately $155.6 million and a net margin of 20.1%, showcasing its profitability amid rising demand for long-term lease agreements.
- Risk and Valuation Comparison: Community Healthcare Trust faces risks from its concentration in the healthcare sector, particularly economic fluctuations in Texas and Florida, while Sabra is sensitive to rising interest rates that could increase debt costs; however, its future earnings estimates suggest a more attractive valuation, prompting investors to weigh market outlooks in their decisions.
See More
Analysis of Healthcare Real Estate Investment Prospects
- Community Healthcare Trust Overview: Community Healthcare Trust focuses on outpatient facilities in non-urban and suburban areas, owning nearly 198 properties across 35 states, with FY 2025 revenue of approximately $121.2 million, reflecting a 4.7% growth, indicating stability and growth potential in the healthcare real estate niche.
- Sabra Health Trust Advantages: Sabra Health Trust boasts a portfolio of nearly 361 properties and over 36,412 beds, with FY 2025 revenue nearing $774.6 million and a growth rate of about 10.2%, while its 20.1% net margin highlights profitability in the long-term lease and senior housing market.
- Financial Health Comparison: As of December 2025, Community Healthcare Trust has a debt-to-equity ratio of 1.2x and a current ratio of approximately 0.2x, whereas Sabra's ratios are 0.9x and 0.6x respectively, showcasing Sabra's relative advantage in financial leverage and liquidity.
- Market Risks and Opportunities: Community Healthcare Trust faces concentration risks in the healthcare sector, with about 26.7% of annual rent from Texas and Florida, while Sabra is sensitive to rising interest rates that could increase debt costs, requiring investors to weigh each company's market risks against future growth potential.
See More
Sabra Health Care REIT Q1 2026 Earnings Call Insights
- Strong Investment Liquidity: Sabra has closed or been awarded $400 million in investments year-to-date in Q1 2026, indicating robust deal flow and a strong competitive position in the market, with expectations to materially exceed total investments from 2025.
- Increased Private Pay Concentration: For the first time, private pay concentration has surpassed 50% of the portfolio, enhancing revenue stability and strengthening the company's market position in the healthcare sector.
- Solid Financial Performance: The normalized FFO per share for Q1 was $0.38, and normalized AFFO per share was $0.39, reflecting ongoing improvements in profitability, although management did not provide new per-share guidance figures.
- Strong Dividend Coverage: The Board declared a quarterly cash dividend of $0.30 per share, with a coverage ratio of 77%, indicating robust cash flow management that helps bolster investor confidence.
See More
Sabra (SBRA) Q1 2026 Earnings Transcript
See More
Sabra Health Care Declares Quarterly Dividend of $0.30
- Quarterly Dividend Announcement: Sabra Health Care declares a quarterly dividend of $0.30 per share, consistent with previous distributions, indicating the company's stable cash flow and commitment to shareholder returns.
- Yield Analysis: The forward yield of 5.9% reflects the company's attractiveness in the current market environment, potentially drawing more investor interest towards its stock.
- Financial Performance: Sabra Health Care reported FFO of $0.36, missing expectations by $0.01, while revenue of $211.9 million exceeded forecasts by $9.93 million, demonstrating the company's resilience in revenue growth.
- Future Outlook: Sabra anticipates FFO growth between 4.9% and 5.4% for 2026, while increasing investments in SHOP to capitalize on the upcoming silver tsunami market opportunities.
See More
Sabra Health Care Q1 Earnings Announcement Scheduled
- Earnings Release Date: Sabra Health Care (SBRA) is set to announce its Q1 2023 earnings on April 29th after market close, with consensus estimates predicting a Funds From Operations (FFO) of $0.37 and revenue of $216.44 million.
- FFO Growth Outlook: The company anticipates an FFO growth rate between 4.9% and 5.4% for 2026, indicating a strategic focus on accelerating investments in its Senior Housing Operating Platform (SHOP) to capitalize on demographic trends.
- 2025 Q4 Earnings Review: In its Q4 2025 earnings report, Sabra reported an FFO of $0.36, missing estimates by $0.01, while revenue of $211.9 million exceeded expectations by $9.93 million, demonstrating resilience in revenue growth despite slight FFO shortfall.
- Market Reaction: Although the FFO fell slightly short of expectations, the revenue beat may positively influence the stock price in the short term, reflecting market confidence in the company's future growth potential.
See More
